(Technology Networks) – Clinician-scientists hope to expand the use of blood-based biomarker tests for traumatic brain injury (TBI) to improve identification and escalation of care for patients whose diagnosis otherwise might be missed.
In a study published Oct. 23 in the Journal of Neurosurgery, a multi-institutional research team led by University of Pittsburgh School of Medicine neurosurgery clinician-scientists reported clinical cutoffs for two brain-associated proteins detected in the blood after brain injury, which may help better identify and triage patients. CONTINUE